K. Axcrona Et Al. , "Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide," BJU INTERNATIONAL , vol.110, no.11, pp.1721-1728, 2012
Axcrona, K. Et Al. 2012. Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide. BJU INTERNATIONAL , vol.110, no.11 , 1721-1728.
Axcrona, K., Aaltomaa, S., da Silva, C. M., Ozen, H., Damber, J., Tanko, L. B., ... Colli, E.(2012). Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide. BJU INTERNATIONAL , vol.110, no.11, 1721-1728.
Axcrona, Karol Et Al. "Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide," BJU INTERNATIONAL , vol.110, no.11, 1721-1728, 2012
Axcrona, Karol Et Al. "Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide." BJU INTERNATIONAL , vol.110, no.11, pp.1721-1728, 2012
Axcrona, K. Et Al. (2012) . "Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide." BJU INTERNATIONAL , vol.110, no.11, pp.1721-1728.
@article{article, author={Karol Axcrona Et Al. }, title={Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide}, journal={BJU INTERNATIONAL}, year=2012, pages={1721-1728} }